Company news
Telomir Pharmaceuticals, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes
July 1, 2024
Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1
May 29, 2024
Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support
May 15, 2024
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
April 15, 2024
Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
March 25, 2024
Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th
March 21, 2024
Telomir Pharmaceuticals Announces Closing of Initial Public Offering
February 12, 2024
Decks
The 5 newest of 9 decks. Every deck is listed under its year.
- Investor Presentation (July 2026)
Investor deck · 25 slides · July 2026
- Investor Presentation (April 2026)
Investor deck · 43 slides · April 2026
- Investor Presentation (February 2026)
Investor deck · 70 slides · February 2026
- Investor Presentation (November 2025)
Investor deck · 63 slides · November 2025
- Bio Presentation (June 2025)
Conference · 30 slides · June 2025